The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Multiple myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–268 of 268
Schinke, C., Poos, A. M., Bauer, M., John, L., Johnson, S., Deshpande, S., Carrillo, L. F., Alapat, D. V., Rasche, L., Thanendrarajan, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007217 · Cited by 69
Socioeconomic status and multiple myeloma among US blacks and whites
Baris, D., Brown, L. M., Silverman, D. T., Hayes, R., Hoover, R. N., Swanson, G. M., Dosemeci, M., Schwartz, A. G., Liff, J. M., Schoenberg, J. B., et al. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.8.1277 · Cited by 68
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
Garderet, L., Kuhnowski, F., Berge, B., Roussel, M., Escoffre‐Barbe, M., Lafon, I., Facon, T. T. F., Leleu, X. P., Karlin, L., Perrot, A., et al. (2018) · Blood · doi:10.1182/blood-2018-07-863829 · Cited by 68
Self-citationLiu, L., Yu, Z., Cheng, H., Mao, X., Sui, W., Deng, S., Wei, X., Lv, J., Du, C., Xu, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77450-y · Cited by 67
Jephcote, C., Brown, D., Verbeek, T., & Mah, A. (2020) · Environmental Health · doi:10.1186/s12940-020-00582-1 · Cited by 66
Observational study of multiple myeloma in Latin America
On behalf of the International Myeloma Working Group Latin America, Hungria, V., Maiolino, Â., Martınez, G., Duarte, G. O., Bittencourt, R., Peters, L. G. B., Colleoni, G. W. B., de Oliveira, L. C. O., Crusoé, E. D. Q., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2866-9 · Cited by 65
Self-citationHealth-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma
Chakraborty, R., Hamilton, B. K., Hashmi, S. K., Kumar, S. K., & Majhail, N. S. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.03.027 · Cited by 65
Courant, M., Orazio, S., Monnereau, A., Préterre, J., Combe, C., & Rigothier, C. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz211 · Cited by 65
Misund, K., Bruinink, D. H. O., Coward, E., Hoogenboezem, R. M., Rustad, E. H., Sanders, M. A., Rye, M. B., Sponaas, A., van der Holt, B., Zweegman, S., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01597-y · Cited by 65
Zhou, F., Meng, S., Song, H., & Claret, F. X. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.08.002 · Cited by 63
Obesity and multiple myeloma: Emerging mechanisms and perspectives
Tentolouris, A., Ntanasis‐Stathopoulos, I., & Terpos, E. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.003 · Cited by 62
Self-citationVogl, D. T., Wang, T., Pérez, W. S., Stadtmauer, E. A., Heitjan, D. F., Lazarus, H. M., Kyle, R. A., Kamble, R., Weisdorf, D. J., Roy, V., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.05.005 · Cited by 61
Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
Neri, P. E., & Bahlis, N. J. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912802429337 · Cited by 60
Self-citationEngelhardt, M. M., Ihorst, G., Singh, M., Rieth, A., Saba, G., Pellan, M., & Lebioda, A. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.10.002 · Cited by 60
Mutational processes contributing to the development of multiple myeloma
Hoang, P. H., Cornish, A. J., Dobbins, S. E., Kaiser, M., & Houlston, R. S. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0221-9 · Cited by 57
Genetic predisposition for multiple myeloma
Pertesi, M., Went, M., Hansson, M., Hemminki, K., Houlston, R. S., & Nilsson, B. (2020) · Leukemia · doi:10.1038/s41375-019-0703-6 · Cited by 56
Termini, R., Žihala, D., Terpos, E., Perez-Montaña, A., Jelínek, T., Raab, M., Weinhold, N., Mai, E. K., Grab, A. L., Corre, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1594 · Cited by 54
Self-citationResolving the spatial architecture of myeloma and its microenvironment at the single-cell level
John, L., Poos, A. M., Brobeil, A., Schinke, C., Huhn, S., Prokoph, N., Lutz, R., Wagner, B., Zangari, M., Tirier, S. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40584-4 · Cited by 53
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation
Groen, R. W. J., de Rooij, M. F. M., Kocemba‐Pilarczyk, K. A., Reijmers, R. M., de Haan-Kramer, A., Overdijk, M. B., Aalders, L., Rozemuller, H., Martens, A. C., Bergsagel, P. L., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.038133 · Cited by 52
Multiple myeloma and farming. A systematic review of 30 years of research. Where next?
Perrotta, C., Staines, A. S., & Cocco, P. (2008) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-3-27 · Cited by 52
VanValkenburg, M. E., Pruitt, G. I., Brill, I. K., Costa, L. J., Ehtsham, M., Justement, I., Innis-Shelton, R. D., Salzman, D. E., Reddy, E. S. P., Godby, K. N., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0685-2 · Cited by 52
Terpos, E., Musto, P., Engelhardt, M. M., Delforge, M., Cook, G., Gay, F., van de Donk, N. W. C. J., Ntanasis‐Stathopoulos, I., Vangsted, A. J., Driessen, C., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01920-1 · Cited by 52
Self-citationMagrangeas, F., Kuiper, R., Avet‐Loiseau, H., Gouraud, W., Guérin‐Charbonnel, C., Ferrer, L., Aussem, A., Elghazel, H., Suhard, J., Sakissian, H. D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3163 · Cited by 51
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Maura, F., Rustad, E. H., Yellapantula, V., Łuksza, M., Hoyos, D., Maclachlan, K. H., Diamond, B. T., Greenbaum, B. D., Morgan, G., Lesokhin, A., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0689-0 · Cited by 50
Stacul, F., Bertolotto, M., Thomsen, H. S., Pozzato, G., Ugolini, D., Bellin, M., Bongartz, G. M., Clémеnt, O., Heinz‐Peer, G., van der Molen, A. J., et al. (2017) · European Radiology · doi:10.1007/s00330-017-5023-5 · Cited by 49
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAF V600E-mutated multiple myeloma
Giesen, N., Chatterjee, M., Scheid, C., Poos, A. M., Besemer, B., Miah, K., Benner, A., Becker, N., Moehler, T., Metzler, I., et al. (2023) · Blood · doi:10.1182/blood.2022017789 · Cited by 48
Birmann, B. M., Andreotti, G., Roos, A. J. D., Camp, N. J., Chiu, B. C. ‐., Spinelli, J. J., Becker, N., Benhaïm-Luzon, V., Bhatti, P., Boffetta, P., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0762-t · Cited by 46
Abonour, R., Wagner, L. I., Durie, B. G. M., Jagannath, S., Narang, M., Terebelo, H. R., Gasparetto, C., TOOMEY, K. E., Hardin, J. W., Kitali, A., et al. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3446-y · Cited by 45
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
Bruinink, D. H. O., Kuiper, R., van Duin, M., Cupedo, T., van der Velden, V. H. J., Hoogenboezem, R. M., van der Holt, B., Beverloo, H. B., Valent, E. T., Vermeulen, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01217 · Cited by 45
Chang-Chan, D. Y.-L., Ríos, R., Rodríguez‐Barranco, M., Redondo‐Sánchez, D., González, Y., Marcos‐Gragera, R., & Sánchez, M. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02541-1 · Cited by 42
Ludwig, H., Kainz, S., Schreder, M., Zojer, N., & Hinke, A. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101910 · Cited by 42
Gormley, N. J., Fashoyin‐Aje, L. A., Locke, T., Unger, J. M., Little, R. F., Nooka, A. K., Mezzi, K., Popa-McKiver, M., Kobos, R., Biru, Y., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0123 · Cited by 41
LeBlanc, M. R., Hirschey, R., Bryant, A. L., LeBlanc, T. W., & Smith, S. K. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02392-6 · Cited by 39
Moreau, P., Usmani, S. Z., Garfall, A. L., van de Donk, N. W. C. J., Nahi, H., Miguel, J. F. S., Oriol, A., Nooka, A. K., Martin, T. G., Rosiñol, L., et al. (2021) · Blood · doi:10.1182/blood-2021-147915 · Cited by 39
Self-citationImpact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma
Goyal, G., Rajkumar, S. V., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Dispenzieri, A. A., Hwa, Y. L., Fonder, A. L., Hobbs, M., Hayman, S. R., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0419-7 · Cited by 38
Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
Georgakopoulou, R., Fiste, O., Sergentanis, T. Ν., Andrikopoulou, Α., Zagouri, F., Gavriatopoulou, M., Ψαλτοπούλου, Θ., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184179 · Cited by 38
Self-citationJohnson, D. C., Weinhold, N., Mitchell, J. S., Chen, B., Kaiser, M., Begum, D. B., Hillengaß, J., Bertsch, U., Gregory, W. M., Cairns, D. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10290 · Cited by 37
Harrison, S. J., Cavo, M., de la Rubia, J., Popat, R., Gasparetto, C., Hungria, V., Salwender, H. J., Suzuki, K., Kim, I., Moreau, P., et al. (2019) · Blood · doi:10.1182/blood-2019-126094 · Cited by 37
Self-citationAdhesion Molecules in Multiple Myeloma Oncogenesis and Targeted Therapy
Zerdan, M. B., Nasr, L. F., Kassab, J. T., Saba, L., Ghossein, M., Yaghi, M., Dominguez, B. G., & Chaulagain, C. P. (2022) · International Journal of Hematologic Oncology · doi:10.2217/ijh-2021-0017 · Cited by 37
Experts’ consensus on the definition and management of high risk multiple myeloma
Marcon, C., Simeon, V., Deias, P., Facchin, G., Corso, A., Derudas, D., Montefusco, V., Offidani, M., Petrucci, M. T., Zambello, R., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1096852 · Cited by 37
Wang, Y., Xu, J., Xu, B., Li, P., Yang, Y., Wang, W., Xu, T., Maihemaiti, A., Lan, T., Wang, P., et al. (2023) · Cancer · doi:10.1002/cncr.34641 · Cited by 37
The Association between Metabolic Syndrome and Multiple Myeloma
Ragbourne, S. C., Maghsoodi, N., Streetly, M. J., & Crook, M. A. (2020) · Acta Haematologica · doi:10.1159/000505992 · Cited by 35
Global disparities in patients with multiple myeloma: a rapid evidence assessment
Mateos, M., Ailawadhi, S., Costa, L. J., et al. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00877-9 · Cited by 34
Lee, D. J., El‐Khoury, H., Tramontano, A. C., Alberge, J.-B., Perry, J. F., Davis, M. I., Horowitz, E. M., Redd, R. A., Sakrikar, D. S., Barnidge, D. R., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2023010843 · Cited by 32
Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000491 · Cited by 31
Rand, K. A., Song, C. W., Dean, E. W., Serie, D., Curtin, K., Sheng, X., Hu, D., Huff, C. A., Bernal‐Mizrachi, L., Tomasson, M. H., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-1193 · Cited by 30
Clinical Considerations for Immunoparesis in Multiple Myeloma
Chahin, M., Branham, Z., Fox, A. D., Leurinda, C., & Keruakous, A. R. (2022) · Cancers · doi:10.3390/cancers14092278 · Cited by 30
Samur, A. A., Fulciniti, M., Avet‐Loiseau, H., Lopez, M. A., Derebail, S., Corre, J., Minvielle, S., Magrangeas, F., Moreau, P., Anderson, K. C., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00759-6 · Cited by 28
Frenzel, L., Decaux, O., Macro, M., Belhadj‐Merzoug, K., Manier, S., Touzeau, C., Leleu, X. P., Frère, C., Lecompte, T., Perrot, A., et al. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.11.021 · Cited by 28
Self-citationVisram, A., Rajkumar, S. V., Kapoor, P., Dispenzieri, A. A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Hayman, S. R., Dingli, D., Kourelis, T., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00569-2 · Cited by 27
Han, J., Wang, J., Zhang, Y., Cao, X., Zhou, D., Xu, T., Su, W., & Li, J. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0303-8 · Cited by 26
Choa, R., Panaroni, C., Bhatia, R., & Raje, N. S. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010822 · Cited by 24
Martin, T. G., Moreau, P., Usmani, S. Z., Garfall, A. L., Mateos, M., Miguel, J. F. S., Oriol, A., Nooka, A. K., Rosiñol, L., Chari, A., et al. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2023.11.001 · Cited by 24
Self-citationAnalytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma
van Beers, E. H., Huigh, D., Bosman, L., de Best, L., Kuiper, R., Spaan, M., van Duin, M., Sonneveld, P., Dumee, B., & van Vliet, M. H. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.10.010 · Cited by 23
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More
Kostopoulos, I. V., Ntanasis‐Stathopoulos, I., Rousakis, P., Eleutherakis‐Papaiakovou, E., Panteli, C., Malandrakis, P., Angelis, N., Kanellias, N., Orologas‐Stavrou, N., Papanota, A., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01606 · Cited by 22
Self-citationLesokhin, A. M., Arnulf, B., Niesvizky, R., Mohty, M., Bahlis, N. J., Tomasson, M. H., Rodríguez‐Otero, P., Quach, H., Raje, N. S., Iida, S., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.16_suppl.8006 · Cited by 21
Self-citationClavero, E., Sánchez‐Maldonado, J. M., Macauda, A., ter Horst, R., Sampaio‐Marques, B., Jurczyszyn, A. J., Clay‐Gilmour, A., Stein, A., Hildebrandt, M. A. T., Weinhold, N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108500 · Cited by 21
Yong, K., Hinsley, S., Auner, H. W., Bygrave, C., Kaiser, M., Ramasamy, K., Tute, R. M. D., Sherratt, D., Flanagan, L. M., Garg, M. K., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278399 · Cited by 20
Fischer, J., Knop, S. T., Danhof, S., Einsele, H., Keller, D., & Löffler, C. (2022) · BMC Cancer · doi:10.1186/s12885-022-10101-9 · Cited by 20
Salek, S., Ionova, T., Olíva, E. N., Andreas, M., Skoetz, N., Kreuzberger, N., & Laane, E. (2022) · Cancers · doi:10.3390/cancers14236007 · Cited by 20
Macauda, A., Piredda, C., Clay‐Gilmour, A., Sáinz, J., Buda, G., Markiewicz, M., Barington, T., Ziv, E., Hildebrandt, M. A. T., Belachew, A. A., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33547 · Cited by 17
Monoclonal gammopathy of increasing significance: time to screen?
Chen, L., Drayson, M. T., Bunce, C. M., & Ramasamy, K. (2022) · Haematologica · doi:10.3324/haematol.2022.281802 · Cited by 17
Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective
Ibrahim, A., Chamseddine, N., Cheikh, J. E., Hanna, C., Moukadem, W., Nasr, F. L., Younis, A. T., & Bazarbachi, A. A. (2022) · Clinical Hematology International · doi:10.1007/s44228-022-00017-3 · Cited by 16
Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
Wang, B., Derman, B. A., Langerman, S. S., Johnson, J., Zhang, W., Jakubowiak, A. J., & Chiu, B. C. ‐. (2022) · Cancers · doi:10.3390/cancers14215331 · Cited by 14
Disparities in multiple myeloma among African Americans
Bhutani, M., Lonial, S., & Mikhael, J. R. (2022) · Journal of the National Medical Association · doi:10.1016/j.jnma.2022.10.001 · Cited by 9
Prevalence of MGCS Among Patients With Monoclonal Gammopathies
Theodorakakou, F., Fotiou, D., Gavriatopoulou, M., Ntanasis‐Stathopoulos, I., Spiliopoulou, V., Malandrakis, P., Migkou, M., Eleutherakis‐Papaiakovou, E., Kanellias, N., Terpos, E., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000908 · Cited by 8
Self-citationBertelsen, L. D., Nielsen, L. H., Christensen, H. S., et al. (2022) · European Journal Of Haematology · doi:10.1111/ejh.13904 · Cited by 6
Lecat, C. S. Y., Fisher, A., Atta, M., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07587-9 · Cited by 6
Cited by
Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma
Nardone, C., Gao, J., Seo, H.-S., Mintseris, J., Ort, L., Yip, M. C. J., Negasi, M., Besschetnova, A. K., Kamitaki, N., Gygi, S. P., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.05.030 · Cited by 22
Metadata
- Authors
- Malard, F., Neri, P., Bahlis, N. J., Terpos, E., Moukalled, N., Hungria, V. T. M., Manier, S., & Mohty, M.
- Venue
- Nature Reviews Disease Primers
- Published
- 2024-06-27
- Volume
- 10
- Issue
- 1
- Pages
- 45-45
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4400094382
- Cited by
- 337
- References
- 268
- FWCI
- 43.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.